599 filings
Page 3 of 30
6-K
cua2ykbjthf3cfy 6wz
1 Mar 23
Current report (foreign)
4:30pm
6-K
kzur f3kge
6 Jan 23
Current report (foreign)
4:49pm
6-K
pm4 0n5p9
30 Nov 22
Current report (foreign)
9:08pm
6-K
q5jd0ky
29 Nov 22
Current report (foreign)
4:58pm
6-K
6b06r9rxzk3uy9fi
15 Nov 22
Current report (foreign)
4:43pm
6-K
rtd9nve98xb0f0cfhom1
9 Nov 22
Portage Biotech Announces Clinical Trial Collaboration Agreement with Merck
4:01pm
6-K/A
qsfo ta0k0v2c
12 Oct 22
Financial Statements for the years ended Report of Independent Registered Public Accounting Firm
5:45pm
6-K
lmep10eu9up5aheih
7 Oct 22
Notice of Annual General Meeting
3:06pm
6-K
juli8i1xu46l
22 Sep 22
Current report (foreign)
4:07pm
6-K
rk6c014 gk
14 Sep 22
Current report (foreign)
10:31am
6-K
1slu2fbe5z owz
29 Aug 22
Current report (foreign)
4:00pm
6-K
fezio0y64f
19 Aug 22
Current report (foreign)
10:54am
424B5
z79vv
19 Aug 22
Prospectus supplement for primary offering
10:52am
6-K
3p343
1 Aug 22
Current report (foreign)
4:48pm
D
plthui81qg cz3bb
29 Jul 22
$34.64M in equity, sold $34.64M, 4 investors
6:15pm
6-K
w61v99
19 Jul 22
Portage Biotech Acquires Outstanding Minority Interest of Invariant Natural Killer T cell (iNKT) Agonist Platform
9:01am
6-K
cqjzjs g7zh5328r
8 Jul 22
Current report (foreign)
8:58am
6-K
uy7c67i
7 Jul 22
Portage Biotech Bolsters Pipeline with Acquisition of Four Candidates Targeting the Adenosine Pathway
8:30am
6-K
fdspepd3a5g4
23 Jun 22
Territory of the British Virgin Islands
4:05pm